Home Health & Hospice Weekly News Roundup

Our weekly list of news, reports, and information about home health and hospice care. Learn about new studies, trends, CMS regulations and more.

Home Care Industry Strives to Stay Off ‘Regulatory Menu’

Throughout the past few years, home-based care — especially the private-duty industry — has gained greater recognition as a key part of the overall health care continuum. With that increased prominence, though, has come greater scrutiny. As part of an increase in attention, home health and hospice providers alike have made strategic moves to add or expand personal care services in their business, both through merger-and-acquisition deals and partnership arrangements. The Centers for Medicare & Medicaid Services’ (CMS) decision to officially add non-skilled in-home care services as a supplemental benefit for Medicare Advantage plans starting in 2019 has only added fuel to that fire. The private-duty industry’s continued rise to prominence has made it a regulatory target on state and national levels alike, industry leaders told Home Health Care News.

Bayada, BrightSpring Make Moves to Serve Younger Home Health Patients

With the massive age wave set to hit the United States, in-home care receives a lot of attention as a way to meet seniors’ needs. However, there are many other populations being served by home health and private duty companies, and in some cases a significant portion of revenue for these enterprises comes from serving younger people. Bayada Home Health Care and BrightSpring Health Services — formerly known as ResCare — are two examples. These companies are already serving patients of all ages, including children, and are dedicating resources toward expanding these care lines and showcasing their value.

Amedisys Inc (AMED) Expected to Announce Quarterly Sales of $410.21 Million

Analysts expect that Amedisys Inc (NASDAQ:AMED) will announce sales of $410.21 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Amedisys’ earnings. The lowest sales estimate is $399.50 million and the highest is $415.47 million. Amedisys reported sales of $380.16 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 7.9%. The firm is expected to report its next quarterly earnings results on Tuesday, November 6th.

Zacks: Analysts Expect LHC Group, Inc. (LHCG) Will Announce Quarterly Sales of $512.18 Million

Equities research analysts expect that LHC Group, Inc. (NASDAQ:LHCG) will report $512.18 million in sales for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for LHC Group’s earnings, with estimates ranging from $510.00 million to $516.00 million. LHC Group posted sales of $272.87 million in the same quarter last year, which would indicate a positive year over year growth rate of 87.7%. The business is scheduled to report its next earnings results on Monday, November 5th.

GAM Holding AG Raises Position in Kindred Healthcare, Inc. (NYSE:KND)

GAM Holding AG raised its holdings in shares of Kindred Healthcare, Inc. (NYSE:KND) by 27.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 63,372 shares of the health services provider’s stock after buying an additional 13,551 shares during the period. GAM Holding AG owned about 0.07% of Kindred Healthcare worth $570,000 at the end of the most recent quarter.